2025 AOAO Annual Fall Meeting

Gaylord National, Washington DC
October 23-25, 2025

Thank You to Our Exhibitors!

Click on the exhibitor/sponsor logo to view more information on the organization's website.

Silver Exhibitor

	The orthopaedics solutions of J&J MedTech provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. J&J MedTech's solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS Enabling Tech portfolio, are designed to advance patient care while delivering clinical and economic value.

The orthopaedics solutions of J&J MedTech provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. J&J MedTech's solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS Enabling Tech portfolio, are designed to advance patient care while delivering clinical and economic value.

	Shoulder Innovations develops leading edge shoulder arthroplasty technology. The InSet™ Shoulder System, is a fully integrated anatomic and reverse system featuring the InSet™ glenoid, a game-changing design backed by long term data. Please visit our exhibit to learn more: www.shoulderinnovations.com

Shoulder Innovations develops leading edge shoulder arthroplasty technology. The InSet™ Shoulder System, is a fully integrated anatomic and reverse system featuring the InSet™ glenoid, a game-changing design backed by long term data. Please visit our exhibit to learn more: www.shoulderinnovations.com

Bronze Exhibitor

	Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.

	Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes.

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes.

	About Zimmer Biomet Zimmer Biomet focuses on alleviating pain and improving the quality of life for people around the world through its innovative, collaborative ecosystem of outstanding products and solutions. As a trusted partner, Zimmer Biomet strives to deliver optimal clinical and economical outcomes in musculoskeletal health. Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic products; and related surgical products. We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives. We have operations in more than 25 countries around the world and sell products in more than 100 countries.

About Zimmer Biomet

Zimmer Biomet focuses on alleviating pain and improving the quality of life for people around the world through its innovative, collaborative ecosystem of outstanding products and solutions. As a trusted partner, Zimmer Biomet strives to deliver optimal clinical and economical outcomes in musculoskeletal health.

Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic products; and related surgical products. We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives. We have operations in more than 25 countries around the world and sell products in more than 100 countries.

Exhibitor

	The American Orthopaedic Foot & Ankle Society® (AOFAS) mobilizes our dynamic community of foot and ankle orthopaedic surgeons to improve patient care through education, research, and advocacy. As the premier global organization for foot and ankle care, AOFAS delivers exceptional events and resources for continuous education, funds and promotes innovative research, and broadens patient understanding of foot and ankle conditions and treatments. By emphasizing collaboration and excellence, AOFAS inspires ever-increasing levels of professional performance leading to improved patient outcomes. About Foot and Ankle Orthopaedic Surgeons Foot and Ankle Orthopaedic Surgeons are medical doctors who specialize in the diagnosis and treatment of injuries, diseases, and other conditions of the foot and ankle. Their comprehensive education and training include four years of medical school, five years of residency training in orthopaedic surgery, and a one- or two-year fellowship focused on foot and ankle care. No other healthcare provider has the depth and breadth of experience to treat the full spectrum of foot and ankle conditions.

The American Orthopaedic Foot & Ankle Society® (AOFAS) mobilizes our dynamic community of foot and ankle orthopaedic surgeons to improve patient care through education, research, and advocacy. As the premier global organization for foot and ankle care, AOFAS delivers exceptional events and resources for continuous education, funds and promotes innovative research, and broadens patient understanding of foot and ankle conditions and treatments. By emphasizing collaboration and excellence, AOFAS inspires ever-increasing levels of professional performance leading to improved patient outcomes.

About Foot and Ankle Orthopaedic Surgeons

Foot and Ankle Orthopaedic Surgeons are medical doctors who specialize in the diagnosis and treatment of injuries, diseases, and other conditions of the foot and ankle. Their comprehensive education and training include four years of medical school, five years of residency training in orthopaedic surgery, and a one- or two-year fellowship focused on foot and ankle care. No other healthcare provider has the depth and breadth of experience to treat the full spectrum of foot and ankle conditions.

	At Biocomposites, we are proud to be driving improved outcomes across a wide range of clinical applications for patients and surgeons. Our team of specialists is singularly focused on the development of innovative calcium and polymer compounds for surgical use. Based in Keele, UK with global operations across Europe, USA, Canada, Argentina, China and India, our products are now used in over 1 million procedures every year and sold in more than 100 countries around the world.

At Biocomposites, we are proud to be driving improved outcomes across a wide range of clinical applications for patients and surgeons. Our team of specialists is singularly focused on the development of innovative calcium and polymer compounds for surgical use. Based in Keele, UK with global operations across Europe, USA, Canada, Argentina, China and India, our products are now used in over 1 million procedures every year and sold in more than 100 countries around the world.

	CONMED is a global medical technology company that specializes in surgical products and services that allow our physician customers to deliver high quality care. It’s our mission to enable healthcare providers around the world to deliver exceptional outcomes for patients through accessible CONMED solutions.

CONMED is a global medical technology company that specializes in surgical products and services that allow our physician customers to deliver high quality care.

It’s our mission to enable healthcare providers around the world to deliver exceptional outcomes for patients through accessible CONMED solutions.

	ENROUTE® helps patients prepare better and recover faster from surgery through a four-week nutrition program containing FDA Medical Foods, educational resources, and tailored dietitian support.

ENROUTE® helps patients prepare better and recover faster from surgery through a four-week nutrition program containing FDA Medical Foods, educational resources, and tailored dietitian support.

	Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more for more information and connect with us on LinkedIn, YouTube and Instagram.

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more for more information and connect with us on LinkedIn, YouTube and Instagram.

	FX Shoulder Solutions is a global leader in the shouder arthroplasty market offering a unique-to-market, comprehensive, and innovative portfolio with options from stemless to revision. The FX portfolio allows surgeons intraoperative options to adapt the system to the patient and not the patient to the system. FX has a US headquarters in Addison, Texas.

FX Shoulder Solutions is a global leader in the shouder arthroplasty market offering a unique-to-market, comprehensive, and innovative portfolio with options from stemless to revision. The FX portfolio allows surgeons intraoperative options to adapt the system to the patient and not the patient to the system. FX has a US headquarters in Addison, Texas.

	Innomed, Inc., a developer of instruments for orthopedic surgery, continues to introduce new and innovative products. We offer an array of unique instruments and patient positioning devices, designed by or in conjunction with orthopedic surgeons and surgical professionals.

Innomed, Inc., a developer of instruments for orthopedic surgery, continues to introduce new and innovative products. We offer an array of unique instruments and patient positioning devices, designed by or in conjunction with orthopedic surgeons and surgical professionals.

	Medacta is specialized in the design, production, and distribution of innovative orthopedic products and surgical techniques, supporting surgeons with comprehensive and tailored programs of medical education. Medacta is committed to improving the care and well-being of patients focusing on healthcare sustainability. Medacta’s innovation, forged by close collaboration with expert surgeons, began with minimally invasive techniques and has evolved into personalized solutions for every patient.

Medacta is specialized in the design, production, and distribution of innovative orthopedic products and surgical techniques, supporting surgeons with comprehensive and tailored programs of medical education. Medacta is committed to improving the care and well-being of patients focusing on healthcare sustainability. Medacta’s innovation, forged by close collaboration with expert surgeons, began with minimally invasive techniques and has evolved into personalized solutions for every patient.

	Miach Orthopaedics is leading a shift in the treatment of anterior cruciate ligament tears from reconstruction to restoration. The company’s Bridge-Enhanced ACL Restoration (BEAR) Implant is the first medical technology to demonstrate with Level 1 clinical evidence that it enables the body to heal its own torn ACL. Unlike reconstruction, the BEAR Implant does not require a second surgical wound site to remove a healthy tendon from another part of the leg or the use of a donor tendon. The BEAR Implant is an ideal bridge designed to restore the native ACL. Autologous whole blood is combined with the BEAR Implant to form a clot that bridges the gap between the torn ends of the ACL and protects the clot from the harsh synovial environment. The BEAR Implant facilitates the body's own healing response by supporting cell migration and proliferation. Within eight weeks, the BEAR Implant is resorbed and replaced with native cells, collagen and blood vessels, and the new tissue continues to remodel and strengthen over time. The BEAR Implant is indicated for a broad range of tear types and is implanted with an easy, bone-sparing technique.

Miach Orthopaedics is leading a shift in the treatment of anterior cruciate ligament tears from reconstruction to restoration. The company’s Bridge-Enhanced ACL Restoration (BEAR) Implant is the first medical technology to demonstrate with Level 1 clinical evidence that it enables the body to heal its own torn ACL. Unlike reconstruction, the BEAR Implant does not require a second surgical wound site to remove a healthy tendon from another part of the leg or the use of a donor tendon. The BEAR Implant is an ideal bridge designed to restore the native ACL. Autologous whole blood is combined with the BEAR Implant to form a clot that bridges the gap between the torn ends of the ACL and protects the clot from the harsh synovial environment. The BEAR Implant facilitates the body's own healing response by supporting cell migration and proliferation. Within eight weeks, the BEAR Implant is resorbed and replaced with native cells, collagen and blood vessels, and the new tissue continues to remodel and strengthen over time. The BEAR Implant is indicated for a broad range of tear types and is implanted with an easy, bone-sparing technique.

	#1 in Orthopedic Surgicalist Programs - An Innovative Team-Based Approach to Care As the visionaries of the Surgicalist Model, our Orthopedic, Trauma and General Surgery programs are built to align the goals of both healthcare leaders and clinicians to support hospitals and practices for the long-term. Unlike temporary locums staffing fixes, our Surgicalist programs are a long-term solution – designed to better meet the lifestyle expectations of clinicians today while providing consistent staffing and call coverage. Active members of a hospital’s medical staff, our Surgicalists work with hospital leadership, are members of coordinated teams, they serve on committees, and are clinical leaders in the local communities they serve.

#1 in Orthopedic Surgicalist Programs - An Innovative Team-Based Approach to Care

As the visionaries of the Surgicalist Model, our Orthopedic, Trauma and General Surgery programs are built to align the goals of both healthcare leaders and clinicians to support hospitals and practices for the long-term.

Unlike temporary locums staffing fixes, our Surgicalist programs are a long-term solution – designed to better meet the lifestyle expectations of clinicians today while providing consistent staffing and call coverage.

Active members of a hospital’s medical staff, our Surgicalists work with hospital leadership, are members of coordinated teams, they serve on committees, and are clinical leaders in the local communities they serve.

	TheraMicro is at the forefront of revolutionizing surgical treatments for the upper and lower extremity. Our mission is to transform the landscape of musculoskeletal disease treatment with innovative, minimally invasive solutions that yield optimal patient outcomes.

TheraMicro is at the forefront of revolutionizing surgical treatments for the upper and lower extremity. Our mission is to transform the landscape of musculoskeletal disease treatment with innovative, minimally invasive solutions that yield optimal patient outcomes.

	Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement.

Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement.

	Our community of 23,000 employees, including more than 2,300 physicians and advanced practice providers, shares a common vision and mission. We’re cultivating medicine’s next generation of innovators and leaders as we transform the health of the communities we serve in Central Pennsylvania and Northern Maryland.

Our community of 23,000 employees, including more than 2,300 physicians and advanced practice providers, shares a common vision and mission. We’re cultivating medicine’s next generation of innovators and leaders as we transform the health of the communities we serve in Central Pennsylvania and Northern Maryland.